Literature DB >> 17405861

Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria.

Chantal Abergel1, Vincent Monchois, Deborah Byrne, Sabine Chenivesse, Frédérique Lembo, Jean-Claude Lazzaroni, Jean-Michel Claverie.   

Abstract

Part of an ancestral bactericidal system, vertebrate C-type lysozyme targets the peptidoglycan moiety of bacterial cell walls. We report the crystal structure of a protein inhibitor of C-type lysozyme, the Escherichia coli Ivy protein, alone and in complex with hen egg white lysozyme. Ivy exhibits a novel fold in which a protruding five-residue loop appears essential to its inhibitory effect. This feature guided the identification of Ivy orthologues in other Gram-negative bacteria. The structure of the evolutionary distant Pseudomonas aeruginosa Ivy orthologue was also determined in complex with hen egg white lysozyme, and its antilysozyme activity was confirmed. Ivy expression protects porous cell-wall E. coli mutants from the lytic effect of lysozyme, suggesting that it is a response against the permeabilizing effects of the innate vertebrate immune system. As such, Ivy acts as a virulence factor for a number of Gram-negative bacteria-infecting vertebrates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405861      PMCID: PMC1847508          DOI: 10.1073/pnas.0611019104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Implementation of molecular replacement in AMoRe.

Authors:  J Navaza
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-09-21

Review 2.  The phylogeny of proteobacteria: relationships to other eubacterial phyla and eukaryotes.

Authors:  R S Gupta
Journal:  FEMS Microbiol Rev       Date:  2000-10       Impact factor: 16.408

3.  Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme.

Authors:  V Monchois; C Abergel; J Sturgis; S Jeudy; J M Claverie
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

4.  Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein.

Authors:  Geraldine Canny; Elke Cario; Andreas Lennartsson; Urban Gullberg; Ciara Brennan; Ofer Levy; Sean P Colgan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-11-10       Impact factor: 4.052

5.  Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.

Authors:  Geraldine Canny; Ofer Levy; Glenn T Furuta; Sailaja Narravula-Alipati; Richard B Sisson; Charles N Serhan; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx.

Authors:  Colin D Bingle; C Jeremy Craven
Journal:  Hum Mol Genet       Date:  2002-04-15       Impact factor: 6.150

7.  Inducible antibacterial defense system in C. elegans.

Authors:  Gustavo V Mallo; C Léopold Kurz; Carole Couillault; Nathalie Pujol; Samuel Granjeaud; Yuji Kohara; Jonathan J Ewbank
Journal:  Curr Biol       Date:  2002-07-23       Impact factor: 10.834

8.  Expression and anti-bacterial activity of human parotid secretory protein (PSP).

Authors:  C Geetha; S G Venkatesh; B H Fasciotto Dunn; S-U Gorr
Journal:  Biochem Soc Trans       Date:  2003-08       Impact factor: 5.407

Review 9.  Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia.

Authors:  O Levy; G Canny; C N Serhan; S P Colgan
Journal:  Biochem Soc Trans       Date:  2003-08       Impact factor: 5.407

10.  Evidence that acetyl phosphate functions as a global signal during biofilm development.

Authors:  Alan J Wolfe; Dong-Eun Chang; Jason D Walker; Jeanine E Seitz-Partridge; Michael D Vidaurri; Charles F Lange; Birgit M Prüss; Margaret C Henk; John C Larkin; Tyrrell Conway
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

View more
  38 in total

Review 1.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

2.  The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase.

Authors:  Chelsea A Clarke; Edie M Scheurwater; Anthony J Clarke
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

3.  Bayesian Weighing of Electron Cryo-Microscopy Data for Integrative Structural Modeling.

Authors:  Massimiliano Bonomi; Samuel Hanot; Charles H Greenberg; Andrej Sali; Michael Nilges; Michele Vendruscolo; Riccardo Pellarin
Journal:  Structure       Date:  2018-11-01       Impact factor: 5.006

4.  Detection of a lysozyme inhibitor in Proteus mirabilis by a new reverse zymogram method.

Authors:  Lien Callewaert; Lise Vanderkelen; Daphne Deckers; Abram Aertsen; Johan Robben; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

5.  The Rcs two-component system regulates expression of lysozyme inhibitors and is induced by exposure to lysozyme.

Authors:  Lien Callewaert; Kristof G A Vanoirbeek; Ine Lurquin; Chris W Michiels; Abram Aertsen
Journal:  J Bacteriol       Date:  2009-01-09       Impact factor: 3.490

Review 6.  Invertebrate lysozymes: diversity and distribution, molecular mechanism and in vivo function.

Authors:  Joris M Van Herreweghe; Chris W Michiels
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

7.  Identification, structure, and function of a novel type VI secretion peptidoglycan glycoside hydrolase effector-immunity pair.

Authors:  John C Whitney; Seemay Chou; Alistair B Russell; Jacob Biboy; Taylor E Gardiner; Michael A Ferrin; Mitchell Brittnacher; Waldemar Vollmer; Joseph D Mougous
Journal:  J Biol Chem       Date:  2013-07-22       Impact factor: 5.157

8.  Structural evidence for lack of inhibition of fish goose-type lysozymes by a bacterial inhibitor of lysozyme.

Authors:  Peter Kyomuhendo; Inge W Nilsen; Bjørn Olav Brandsdal; Arne O Smalås
Journal:  J Mol Model       Date:  2008-05-20       Impact factor: 1.810

9.  Engineering Escherichia coli for soluble expression and single step purification of active human lysozyme.

Authors:  John W Lamppa; Sam A Tanyos; Karl E Griswold
Journal:  J Biotechnol       Date:  2012-12-07       Impact factor: 3.307

10.  The plasmid-encoded regulator activates factors conferring lysozyme resistance on enteropathogenic Escherichia coli strains.

Authors:  Nina Salinger; Bashkim Kokona; Robert Fairman; Iruka N Okeke
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.